About Day One
Day One is a company based in San Francisco (United States) founded in 2018 by Sam Blackman. It operates as a Direct-to-Consumer (D2C). Day One has raised $190 million across 2 funding rounds from investors including T. Rowe Price, Franklin Templeton and Janus Henderson Investors. The company has 181 employees as of December 31, 2024. Day One has completed 1 acquisition, including Mersana. Day One offers products and services including OJEMDA™ (tovorafenib) and Tovorafenib DAY301.
- Headquarter San Francisco, United States
- Employees 181 as on 31 Dec, 2024
- Founders Sam Blackman
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Day One Biopharmaceuticals, Inc.
-
Annual Revenue
$131.16 M0as on Dec 31, 2024
-
Net Profit
$-95.5 M49.45as on Dec 31, 2024
-
EBITDA
$-215.24 M-4.65as on Dec 31, 2024
-
Total Equity Funding
$190 M (USD)
in 2 rounds
-
Latest Funding Round
$130 M (USD), Series B
Feb 01, 2021
-
Investors
T. Rowe Price
& 10 more
-
Employee Count
181
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Day One
Day One is a publicly listed company on the NASDAQ with ticker symbol DAWN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Day One
Day One offers a comprehensive portfolio of products and services, including OJEMDA™ (tovorafenib) and Tovorafenib DAY301. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A targeted therapy developed for cancer treatment purposes.
A drug candidate explored for oncology treatment solutions.
Unlock access to complete
Unlock access to complete
Funding Insights of Day One
Day One has successfully raised a total of $190M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $130 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $130.0M
-
First Round
First Round
(21 May 2020)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2021 | Amount | Series B - Day One | Valuation | RA Capital Management | |
| May, 2020 | Amount | Series A - Day One | Valuation | Canaan , Atlas Venture |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Day One
Day One has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include T. Rowe Price, Franklin Templeton and Janus Henderson Investors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
US private equity investments are managed by BVF Partners.
|
Founded Year | Domain | Location | |
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Day One
Day One has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Mersana. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Antibody-drug conjugates for cancer treatment are developed by Mersana.
|
2001 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Day One
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Day One Comparisons
Competitors of Day One
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Day One
Frequently Asked Questions about Day One
When was Day One founded?
Day One was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Day One located?
Day One is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Day One a funded company?
Day One is a funded company, having raised a total of $190M across 2 funding rounds to date. The company's 1st funding round was a Series A of $60M, raised on May 21, 2020.
How many employees does Day One have?
As of Dec 31, 2024, the latest employee count at Day One is 181.
What is the annual revenue of Day One?
Annual revenue of Day One is $131.16M as on Dec 31, 2024.
What does Day One do?
Day One Biopharmaceuticals, Inc. is engaged in the development of targeted therapies for cancer treatment, catering to both children and adults. The company operates within the biotechnology sector, emphasizing innovative drug development for oncology. Solutions such as OJEMDA (tovorafenib) are provided to address urgent medical needs. A search development strategy is employed to identify and advance the right programs for patients. The focus is maintained on disrupting traditional drug development to deliver better medicines faster.
What products or services does Day One offer?
Day One offers OJEMDA™ (tovorafenib) and Tovorafenib DAY301.
Is Day One publicly traded?
Yes, Day One is publicly traded on NASDAQ under the ticker symbol DAWN.
How many acquisitions has Day One made?
Day One has made 1 acquisition, including Mersana.
Who are Day One's investors?
Day One has 11 investors. Key investors include T. Rowe Price, Franklin Templeton, Janus Henderson Investors, RA Capital, and Canaan.
What is Day One's ticker symbol?
The ticker symbol of Day One is DAWN on NASDAQ.